Consumption of glaucoma medication
نویسندگان
چکیده
منابع مشابه
Consumption of medication during pregnancy
Method Usingdata fromthe Copenhagen Perinatal Cohort and from the Danish Psychiatric Central Register, we studied the relationship between prenatal exposure to analgesics and the riskof schizophrenia.The effectofprenatal exposurewas adjusted for parental historyof schizophrenia, second-trimester viral infections, concomitantdrug treatmentduringpregnancy, an indexof pregnancycomplications, paren...
متن کاملAntihypertensive Medication Postpones the Onset of Glaucoma
Glaucoma is the second most common irreversible cause of blindness worldwide. It is becoming increasingly important in the context of an aging world population. It possesses a considerable challenge to public health because blindness and visual impairment is costly and have a huge impact on life quality. Raised intraocular pressure (IOP) remains the only successful treatable factor to reduce th...
متن کاملGlaucoma Medication Preferences among Glaucoma Specialists in Mexico
Aim To determine the glaucoma specialists' preferences for the different brands of topical glaucoma medications available in Mexico. Materials and methods A web-based survey was sent to 150 board-certified glaucoma specialists in Mexico, with 14 questions related to brand preferences for all glaucoma medications available in Mexico. Participants were asked to select each glaucoma medication c...
متن کاملAntithrombotic medication and incident open-angle glaucoma.
PURPOSE To determine the associations between the use of antithrombotic drugs and incident open-angle glaucoma (OAG). METHODS Ophthalmic examinations including measurements of the IOP and perimetry were performed at baseline and follow-up in 3939 participants of the prospective population-based Rotterdam Study who did not have OAG at baseline. The use of antithrombotic drugs was monitored con...
متن کاملApproaches to Anti-Glaucoma Medication Nonadherence
LEARNING OBJECTIVES Upon completion of this activity, participants will be able to: 1. Identify barriers to medication adherence among their patients. 2. Take steps to reduce nonadherence among glaucoma patients. 3. Identify glaucoma patients who may benefi t from sustained-release therapies by increasing awareness of nonadherence with eye drop treatment. 4. Compare diff erent drug-delivery sys...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Ophthalmologica Scandinavica
سال: 2001
ISSN: 1395-3907
DOI: 10.1034/j.1600-0420.2001.079001002.x